Erste Group upgraded Vertex Pharmaceuticals (VRTX) to Buy from Hold. The firm expects the company to “develop positively in the coming quarters ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

If approved, TLX250-CDx will become the first commercially available imaging agent to accurately and non-invasively diagnose and characterize clear cell renal cell carcinoma (ccRCC), the most common ...

Vertex Pharmaceuticals has been attracting investor attention due to strong recent stock performance. The company's shares ...